New York Approves Exagen Lupus Test | GenomeWeb

NEW YORK (GenomeWeb News) – Exagen Diagnostics today said that New York has approved its Avise SLE diagnostic, SLE-Systemic Lupus Erythematosus.

The Albuquerque, NM-based firm said that its Avise SLE brand is now available for lupus and connective tissue disease patients across the US. Exagen, which raised $5.3 million last month, runs its CLIA-certified laboratory in Vista, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.